LEVIN JEREMY M
SEC insider (Form 3/4/5 filer). CIK 0001256153. Director at Ovid Therapeutics Inc. (OVID). 7 reported Form 4/5 transactions since Sep 2024; latest on Mar 23, 2026. Located in NEW YORK, NY.
Companies LEVIN JEREMY M has filed insider reports for
- Ovid Therapeutics Inc. (OVID): Director
LEVIN JEREMY M
CIK: 0001256153
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Ovid Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Mar 23, 2026OVID
Ovid Therapeutics Inc.
ExerciseDirect47.3K shares at avg. $1.40$66K - Feb 26, 2026OVID
Ovid Therapeutics Inc.
AwardDirectEmployee Stock Option (Right to Buy)
957K shares- - Dec 15, 2025OVID
Ovid Therapeutics Inc.
ConversionDirect71K shares- - Dec 11, 2025OVID
Ovid Therapeutics Inc.
PurchaseDirectSeries B Convertible Preferred Stock
71 shares- - Dec 11, 2025OVID
Ovid Therapeutics Inc.
PurchaseDirectSeries A Warrant (right to buy)
47.3K shares- - Dec 11, 2025OVID
Ovid Therapeutics Inc.
PurchaseDirectSeries B Warrant (right to buy)
35.5K shares- - Feb 20, 2025OVID
Ovid Therapeutics Inc.
AwardDirectEmployee Stock Option (Right to Buy)
1.7M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 23, 2026 | OVID Ovid Therapeutics Inc. | Exercise | 47,333 | $1.40 | $66,266 | Direct |
| Feb 26, 2026 | OVID Ovid Therapeutics Inc. | Award Employee Stock Option (Right to Buy) | 957,000 | - | - | Direct |
| Dec 15, 2025 | OVID Ovid Therapeutics Inc. | Conversion | 71,000 | - | - | Direct |
| Dec 11, 2025 | OVID Ovid Therapeutics Inc. | Purchase Series B Convertible Preferred Stock | 71 | - | - | Direct |
| Dec 11, 2025 | OVID Ovid Therapeutics Inc. | Purchase Series A Warrant (right to buy) | 47,333 | - | - | Direct |
| Dec 11, 2025 | OVID Ovid Therapeutics Inc. | Purchase Series B Warrant (right to buy) | 35,500 | - | - | Direct |
| Feb 20, 2025 | OVID Ovid Therapeutics Inc. | Award Employee Stock Option (Right to Buy) | 1,650,000 | - | - | Direct |
1-7 of 7 transactions